Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR for Hiv infection who clinical stage iii: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where TENOFOVIR was used for Hiv infection who clinical stage iii.

Most Reported Side Effects for TENOFOVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 509 12.5% 95 41
Virologic failure 409 10.1% 10 10
Drug resistance 317 7.8% 9 26
Exposure during pregnancy 292 7.2% 10 21
Death 225 5.5% 224 17
Immune reconstitution inflammatory syndrome 177 4.4% 33 75
Maternal exposure during pregnancy 173 4.3% 17 28
Treatment failure 163 4.0% 2 7
Drug interaction 141 3.5% 13 48
Premature baby 126 3.1% 22 6
Drug ineffective 125 3.1% 46 23
Acute kidney injury 122 3.0% 33 68
Premature delivery 110 2.7% 0 8
Treatment noncompliance 105 2.6% 4 21
Renal impairment 90 2.2% 6 23

Other Indications for TENOFOVIR

Hiv infection (2,192) Product used for unknown indication (466) Antiretroviral therapy (243) Hepatitis b (200) Chronic hepatitis b (187) Prophylaxis against hiv infection (155) Acquired immunodeficiency syndrome (37) Prophylaxis (31) Antiviral prophylaxis (28) Hiv infection cdc category c (22)

Other Drugs Used for Hiv infection who clinical stage iii

LAMIVUDINE (52) EFAVIRENZ (35) NEVIRAPINE (32) EMTRICITABINE (28) ZIDOVUDINE (27) STAVUDINE (21) ABACAVIR (16) RITONAVIR (10) DIDANOSINE (9) LOPINAVIR (9)

Related Pages

TENOFOVIR Full Profile All Hiv infection who clinical stage iii Drugs TENOFOVIR Demographics TENOFOVIR Timeline